Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Tax Provisions (2022 - 2025)

Atara Biotherapeutics filings provide 4 years of Tax Provisions readings, the most recent being $28000.0 for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 264.71% to $28000.0 in Q3 2025 year-over-year; TTM through Mar 2026 was $31000.0, a 186.11% increase, with the full-year FY2025 number at $31000.0, up 358.33% from a year prior.
  • Tax Provisions hit $28000.0 in Q3 2025 for Atara Biotherapeutics, up from $3000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $28000.0 in Q3 2025 to a low of -$19000.0 in Q3 2023.
  • Median Tax Provisions over the past 4 years was $3000.0 (2025), compared with a mean of $4181.8.
  • The widest YoY moves for Tax Provisions: up 450.0% in 2023, down 290.0% in 2023.
  • Atara Biotherapeutics' Tax Provisions stood at $2000.0 in 2022, then surged by 450.0% to $11000.0 in 2023, then crashed by 272.73% to -$19000.0 in 2024, then skyrocketed by 247.37% to $28000.0 in 2025.
  • The last three reported values for Tax Provisions were $28000.0 (Q3 2025), $3000.0 (Q2 2025), and -$19000.0 (Q4 2024) per Business Quant data.